Nutrition and anabolic pharmacotherapies in the care of burn patients

Nutrition in Clinical Practice

Volumn 29, Issue 5, 2014, Pages 621-630

  Abdullahi, Abdikarim ^a   Jeschke, Marc G ^a,b,c  

^a Canada   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Ross Tilley Burn Centre   (Canada)

Author keywords

burns; micronutrients; nutritional support; wound healing

Indexed keywords

ANABOLIC AGENT; ARGININE; CARBOHYDRATE; COPPER; FAT; GLUCAGON LIKE PEPTIDE 1; GLUTAMINE; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; METFORMIN; OXANDROLONE; PROPRANOLOL; PROTEIN; SELENIUM; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; ZINC;

BURN; BURN PATIENT; CATABOLISM; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HUMAN; HYPERMETABOLISM; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LEAN BODY WEIGHT; LIPID OXIDATION; NUTRITION; PROTEIN DEGRADATION; REVIEW; THERMAL INJURY; WOUND HEALING IMPAIRMENT; BURNS; DIET THERAPY; DRUG EFFECTS; IMMUNITY; IMMUNOLOGY; METABOLISM; NUTRITIONAL STATUS; SKELETAL MUSCLE; WOUND HEALING;

ANABOLIC AGENTS; BURNS; HUMANS; IMMUNITY; MUSCLE, SKELETAL; NUTRITION THERAPY; NUTRITIONAL STATUS; WOUND HEALING;

EID: 84907518126     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533614533129     Document Type: Review

References (114)

1. American Burn Association. Burn incidence and treatment in the United States: 2012 fact sheet. 2012. http://www.ameriburn.org/resources-factsheet.php. Accessed 2012.
2. Keck M, Herndon DH, Kamolz LP, Frey M, Jeschke MG. Pathophysiology of burns. Wien Med Wochenschr. 2009 ; 159 (13-14). 327-336
3. Williams FN, Herndon DN, Jeschke MG. The hypermetabolic response to burn injury and interventions to modify this response. Clin Plast Surg. 2009 ; 36 (4). 583-596
4. Faist E, Schinkel C, Zimmer S. Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg. 1996 ; 20 (4). 454-459
5. Schwacha MG, Nickel E, Daniel T. Burn injury-induced alterations in wound inflammation and healing are associated with suppressed hypoxia inducible factor-1alpha expression. Mol Med. 2008 ; 14 (9-10). 628-633
6. Herndon DN, Tompkins RG. Support of the metabolic response to burn injury. Lancet. 2004 ; 363 (9424). 1895-1902
7. Yu YM, Tompkins RG, Ryan CM, Young VR. The metabolic basis of the increase of the increase in energy expenditure in severely burned patients. JPEN J Parenter Enteral Nutr. 1999 ; 23 (3). 160-168
8. Wilmore DW. Hormonal responses and their effect on metabolism. Surg Clin North Am. 1976 ; 56 (5). 999-1018
9. Caldwell FT, Wallace BH, Cone JB, Manuel L. Control of the hypermetabolic response to burn injury using environmental factors. Ann Surg. 1992 ; 215 (5). 485-491
10. Wolfe RR, Herndon DN, Jahoor F, Miyoshi H, Wolfe M. Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med. 1987 ; 317 (7). 403-408
11. Dolecek R. Endocrine changes after burn trauma - a review. Keio J Med. 1989 ; 38 (3). 262-276
12. Kraft R, Herndon DN, Finnerty CC, Hiyama Y, Jeschke MG. Association of postburn fatty acids and triglycerides with clinical outcome in severely burned children. J Clin Endocrinol Metab. 2013 ; 98 (1). 314-321
13. Wolfe RR, Durkot MJ, Allsop JR, Burke JF. Glucose metabolism in severely burned patients. Metabolism. 1979 ; 28 (10). 1031-1039
14. Wolfe RR, Herndon DN, Peters EJ, Jahoor F, Desai MH, Holland OB. Regulation of lipolysis in severely burned children. Ann Surg. 1987 ; 206 (2). 214-221
15. Porter C, Hurren NM, Herndon DN, Borsheim E. Whole body and skeletal muscle protein turnover in recovery from burns. Int J Burns Trauma. 2013 ; 3 (1). 9-17
16. Wolfe RR, Shaw JH, Durkot MJ. Energy metabolism in trauma and sepsis: the role of fat. Prog Clin Biol Res. 1983 ; 111: 89-109
17. Porter C, Herndon DN, Sidossis LS, Borsheim E. The impact of severe burns on skeletal muscle mitochondrial function. Burns. 2013 ; 39 (6). 1039-1047
18. Wolfe RR. The underappreciated role of muscle in health and disease. Am J Clin Nutr. 2006 ; 84 (3). 475-482
19. Rodriguez NA, Jeschke MG, Williams FN, Kamolz LP, Herndon DN. Nutrition in burns: Galveston contributions. JPEN J Parenter Enteral Nutr. 2011 ; 35 (6). 704-714
20. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001 ; 17 (1). 107-124
21. Gauglitz GG, Herndon DN, Kulp GA, Meyer WJ, Jeschke MG. Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab. 2009 ; 94 (5). 1656-1664
22. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 ; 345 (19). 1359-1367
23. Barrow RE, Mlcak R, Barrow LN, Hawkins HK. Increased liver weights in severely burned children: comparison of ultrasound and autopsy measurements. Burns. 2004 ; 30 (6). 565-568
24. O'Sullivan ST, O'Connor TP. Immunosuppression following thermal injury: the pathogenesis of immunodysfunction. Br J Plast Surg. 1997 ; 50 (8). 615-623
25. Mannick JA, Rodrick ML, Lederer JA. The immunologic response to injury. J Am Coll Surg. 2001 ; 193 (3). 237-244
26. Marik PE, Flemmer M. The immune response to surgery and trauma: implications for treatment. J Trauma Acute Care Surg. 2012 ; 73 (4). 801-808
27. Stoecklein VM, Osuka A, Lederer JA. Trauma equals danger - damage control by the immune system. J Leukoc Biol. 2012 ; 92 (3). 539-551
28. Moore FA, Moore EE, Read RA. Postinjury multiple organ failure: role of extrathoracic injury and sepsis in adult respiratory distress syndrome. New Horiz. 1993 ; 1 (4). 538-549
29. Deitch EA. Multiple organ failure: pathophysiology and potential future therapy. Ann Surg. 1992 ; 216 (2). 117-134
30. Schwacha MG. Macrophages and post-burn immune dysfunction. Burns. 2003 ; 29 (1). 1-14
31. Bielefeld KA, Amini-Nik S, Alman BA. Cutaneous wound healing: recruiting developmental pathways for regeneration. Cell Mol Life Sci. 2013 ; 70 (12). 2059-2081
32. Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res. 2010 ; 89 (3). 219-229
33. Rodriguez PG, Felix FN, Woodley DT, Shim EK. The role of oxygen in wound healing: a review of the literature. Dermatol Surg. 2008 ; 34 (9). 1159-1169
34. Bishop A. Role of oxygen in wound healing. J Wound Care. 2008 ; 17 (9). 399-402
35. Jones SG, Edwards R, Thomas DW. Inflammation and wound healing: the role of bacteria in the immuno-regulation of wound healing. Int J Low Extrem Wounds. 2004 ; 3 (4). 201-208
36. Edwards R, Harding KG. Bacteria and wound healing. Curr Opin Infect Dis. 2004 ; 17 (2). 91-96
37. Barret JP, Jeschke MG, Herndon DN. Fatty infiltration of the liver in severely burned pediatric patients: autopsy findings and clinical implications. J Trauma. 2001 ; 51 (4). 736-739
38. Kulp GA, Tilton RG, Herndon DN, Jeschke MG. Hyperglycemia exacerbates burn-induced liver inflammation via noncanonical nuclear factor-kappaB pathway activation. Mol Med. 2012 ; 18: 948-956
39. Mecott GA, Al-Mousawi AM, Gauglitz GG, Herndon DN, Jeschke MG. The role of hyperglycemia in burned patients: evidence-based studies. Shock. 2010 ; 33 (1). 5-13
40. Martindale RG, McClave SA, Vanek VW, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition: Executive Summary. Crit Care Med. 2009 ; 37 (5). 1757-1761
41. Rousseau AF, Losser MR, Ichai C, Berger MM. ESPEN endorsed recommendations: nutritional therapy in major burns. Clin Nutr. 2013 ; 32 (4). 497-502
42. Prelack K, Dylewski M, Sheridan RL. Practical guidelines for nutritional management of burn injury and recovery. Burns. 2007 ; 33 (1). 14-24
43. Jeschke MG, Kalmolz LP, Shahrokhi S Burn Care and Treatment. Toronto, Canada: Springer Vienna ; 2013 :
44. Mullen JL, Buzby GP, Waldman MT, Gertner MH, Hobbs CL, Rosato EF. Prediction of operative morbidity and mortality by preoperative nutritional assessment. Surg Forum. 1979 ; 30: 80-82
45. Cunningham-Rundles S, McNeeley DF, Moon A. Mechanisms of nutrient modulation of the immune response. J Allergy Clin Immunol. 2005 ; 115 (6). 1119-1129
46. Huschak G, Zur Nieden K, Hoell T, Riemann D, Mast H, Stuttmann R. Olive oil based nutrition in multiple trauma patients: a pilot study. Intensive Care Med. 2005 ; 31 (9). 1202-1208
47. Kurmis R, Parker A, Greenwood J. The use of immunonutrition in burn injury care: where are we?. J Burn Care Res. 2010 ; 31 (5). 677-691
48. Wischmeyer PE. The glutamine story: where are we now?. Curr Opin Crit Care. 2006 ; 12 (2). 142-148
49. Alexander JW. Bacterial translocation during enteral and parenteral nutrition. Proc Nutr Soc. 1998 ; 57 (3). 389-393
50. Peng X, Yan H, You Z, Wang P, Wang S. Glutamine granule-supplemented enteral nutrition maintains immunological function in severely burned patients. Burns. 2006 ; 32 (5). 589-593
51. Wilmore DW. The effect of glutamine supplementation in patients following elective surgery and accidental injury. J Nutr. 2001 ; 131 (9). 2543S - 2551S
52. Wischmeyer PE, Lynch J, Liedel J, et al. Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med. 2001 ; 29 (11). 2075-2080
53. Garrel D. The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns. JPEN J Parenter Enteral Nutr. 2004 ; 28 (2). 123
54. Garrel D, Patenaude J, Nedelec B, et al. Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: a prospective, controlled, randomized clinical trial. Crit Care Med. 2003 ; 31 (10). 2444-2449
55. Appleton J. Arginine: clinical potential of a semi-essential amino. Altern Med Rev. 2002 ; 7 (6). 512-522
56. Yan H, Peng X, Huang Y, Zhao M, Li F, Wang P. Effects of early enteral arginine supplementation on resuscitation of severe burn patients. Burns. 2007 ; 33 (2). 179-184
57. Yu YM, Sheridan RL, Burke JF, Chapman TE, Tompkins RG, Young VR. Kinetics of plasma arginine and leucine in pediatric burn patients. Am J Clin Nutr. 1996 ; 64 (1). 60-66
58. Bower RH, Cerra FB, Bershadsky B, et al. Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med. 1995 ; 23 (3). 436-449
59. Marin VB, Rodriguez-Osiac L, Schlessinger L, Villegas J, Lopez M, Castillo-Duran C. Controlled study of enteral arginine supplementation in burned children: impact on immunologic and metabolic status. Nutrition. 2006 ; 22 (7-8). 705-712
60. Gamliel Z, DeBiasse MA, Demling RH. Essential microminerals and their response to burn injury. J Burn Care Rehabil. 1996 ; 17 (3). 264-272
61. Gottschlich MM, Mayes T, Khoury J, Warden GD. Hypovitaminosis D in acutely injured pediatric burn patients. J Am Diet Assoc. 2004 ; 104 (6). 931-941
62. Schumann AD, Paxton RL, Solanki NS, et al. Vitamin D deficiency in burn patients. J Burn Care Res. 2012 ; 33 (6). 731-735
63. Klein GL. Burn-induced bone loss: importance, mechanisms, and management. J Burns Wounds. 2006 ; 5: e5
64. Berger MM, Shenkin A. Vitamins and trace elements: practical aspects of supplementation. Nutrition. 2006 ; 22 (9). 952-955
65. Berger MM, Binnert C, Chiolero RL, et al. Trace element supplementation after major burns increases burned skin trace element concentrations and modulates local protein metabolism but not whole-body substrate metabolism. Am J Clin Nutr. 2007 ; 85 (5). 1301-1306
66. Berger MM, Baines M, Raffoul W, et al. Trace element supplementation after major burns modulates antioxidant status and clinical course by way of increased tissue trace element concentrations. Am J Clin Nutr. 2007 ; 85 (5). 1293-1300
67. Berger MM, Shenkin A. Trace element requirements in critically ill burned patients. J Trace Elem Med Biol. 2007 ; 21: 44-48
68. Liusuwan RA, Palmieri T, Warden N, Greenhalgh DG. Impaired healing because of copper deficiency in a pediatric burn patient: a case report. J Trauma. 2008 ; 65 (2). 464-466
69. Sakurai Y, Aarsland A, Herndon DN, et al. Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann Surg. 1995 ; 222 (3). 283-297
70. Pidcoke HF, Wade CE, Wolf SE. Insulin and the burned patient. Crit Care Med. 2007 ; 35 (9). S524 - S530
71. Ferrando AA, Chinkes DL, Wolf SE, Matin S, Herndon DN, Wolfe RR. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg. 1999 ; 229 (1). 11-18
72. Wolfe RR, Miller HI, Spitzer JJ. Glucose and lactate kinetics in burn shock. Am J Physiol. 1977 ; 232 (4). E415 - E418
73. Gore DC, Ferrando A, Barnett J, et al. Influence of glucose kinetics on plasma lactate concentration and energy expenditure in severely burned patients. J Trauma. 2000 ; 49 (4). 673-678
74. Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma. 2001 ; 51 (3). 540-544
75. Gore DC, Chinkes DL, Hart DW, Wolf SE, Herndon DN, Sanford AP. Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med. 2002 ; 30 (11). 2438-2442
76. Jeschke MG, Klein D, Bolder U, Einspanier R. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology. 2004 ; 145 (9). 4084-4093
77. Jeschke MG, Klein D, Herndon DN. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg. 2004 ; 239 (4). 553-560
78. Pierre EJ, Barrow RE, Hawkins HK, et al. Effects of insulin on wound healing. J Trauma. 1998 ; 44 (2). 342-345
79. Rojas Y, Finnerty CC, Radhakrishnan RS, Herndon DN. Burns: an update on current pharmacotherapy. Expert Opin Pharmacother. 2012 ; 13 (17). 2485-2494
80. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008 ; 358 (2). 125-139
81. Jeschke MG. Clinical review: glucose control in severely burned patients - current best practice. Crit Care. 2013 ; 17 (4). 232
82. Jeschke MG, Kraft R, Emdad F, Kulp GA, Williams FN, Herndon DN. Glucose control in severely thermally injured pediatric patients: what glucose range should be the target?. Ann Surg. 2010 ; 252 (3). 521-528
83. Gore DC. Insulin-like growth factor I in hypercatabolic states. Growth Horm IGF Res. 1998 ; 8: 115-116
84. Boulware SD, Tamborlane WV, Matthews LS, Sherwin RS. Diverse effects of insulin-like growth factor I on glucose, lipid, and amino acid metabolism. Am J Physiol. 1992 ; 262 (1, pt 1). E130 - E133
85. Strock LL, Singh H, Abdullah A, Miller JA, Herndon DN. The effect of insulin-like growth factor I on postburn hypermetabolism. Surgery. 1990 ; 108 (2). 161-164
86. Herndon DN, Ramzy PI, DebRoy MA, et al. Muscle protein catabolism after severe burn: effects of IGF-1/IGFBP-3 treatment. Ann Surg. 1999 ; 229 (5). 713-722
87. Meier JJ, Nauck MA. Glucagon-like peptide 1(GLP-1) in biology and pathology. Diabetes Metab Res Rev. 2005 ; 21 (2). 91-117
88. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007 ; 132 (6). 2131-2157
89. Nauck MA. Unraveling the science of incretin biology. Am J Med. 2009 ; 122 (6). S3 - S10
90. Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest. 1993 ; 91 (1). 301-307
91. Deane AM, Chapman MJ, Fraser RJ, Burgstad CM, Besanko LK, Horowitz M. The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study. Crit Care. 2009 ; 13 (3). R67
92. Dachicourt N, Serradas P, Bailbe D, Kergoat M, Doare L, Portha B. Glucagon-like peptide-1(7-36)-amide confers glucose sensitivity to previously glucose-incompetent beta-cells in diabetic rats: in vivo and in vitro studies. J Endocrinol. 1997 ; 155 (2). 369-376
93. Mecott GA, Herndon DN, Kulp GA, et al. The use of exenatide in severely burned pediatric patients. Crit Care. 2010 ; 14 (4). R153
94. Gore DC, Herndon DN, Wolfe RR. Comparison of peripheral metabolic effects of insulin and metformin following severe burn injury. J Trauma. 2005 ; 59 (2). 316-323
95. Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med. 1995 ; 333 (9). 550-554
96. Holm C, Horbrand F, Mayr M, von Donnersmarck GH, Muhlbauer W. Acute hyperglycaemia following thermal injury: friend or foe?. Resuscitation. 2004 ; 60 (1). 71-77
97. Gore DC, Wolf SE, Sanford A, Herndon DN, Wolfe RR. Influence of metformin on glucose intolerance and muscle catabolism following severe burn injury. Ann Surg. 2005 ; 241 (2). 334-342
98. Burke JF, Wolfe RR, Mullany CJ, Mathews DE, Bier DM. Glucose requirements following burn injury: parameters of optimal glucose infusion and possible hepatic and respiratory abnormalities following excessive glucose intake. Ann Surg. 1979 ; 190 (3). 274-285
99. Hundal RS, Inzucchi SE. Metformin: new understandings, new uses. Drugs. 2003 ; 63 (18). 1879-1894
100. Gore DC, Wolf SE, Herndon DN, Wolfe RR. Metformin blunts stress-induced hyperglycemia after thermal injury. J Trauma. 2003 ; 54 (3). 555-561
101. Tahrani AA, Varughese GI, Scarpello JH, Hanna FW. Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated?. BMJ. 2007 ; 335 (7618). 508-512
102. Cochran A, Thuet W, Holt B, Faraklas I, Smout RJ, Horn SD. The impact of oxandrolone on length of stay following major burn injury: a clinical practice evaluation. Burns. 2013 ; 39 (7). 1374-1379
103. Hart DW, Wolf SE, Ramzy PI, et al. Anabolic effects of oxandrolone after severe burn. Ann Surg. 2001 ; 233 (4). 556-564
104. Demling RH, Orgill DP. The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury. J Crit Care. 2000 ; 15 (1). 12-17
105. Demling RH. Oxandrolone, an anabolic steroid, enhances the healing of a cutaneous wound in the rat. Wound Repair Regen. 2000 ; 8 (2). 97-102
106. Karim A, Ranney RE, Zagarella J, Maibach HI. Oxandrolone disposition and metabolism in man. Clin Pharmacol Ther. 1973 ; 14 (5). 862-869
107. Wolf SE, Edelman LS, Kemalyan N, et al. Effects of oxandrolone on outcome measures in the severely burned: a multicenter prospective randomized double-blind trial. J Burn Care Res. 2006 ; 27 (2). 131-141
108. Jeschke MG, Finnerty CC, Suman OE, Kulp G, Mlcak RP, Herndon DN. The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn. Ann Surg. 2007 ; 246 (3). 351-362
109. Bulger EM, Jurkovich GJ, Farver CL, Klotz P, Maier RV. Oxandrolone does not improve outcome of ventilator dependent surgical patients. Ann Surg. 2004 ; 240 (3). 472-480
110. Herndon DN, Rodriguez NA, Diaz EC, et al. Long-term propranolol use in severely burned pediatric patients: a randomized controlled study. Ann Surg. 2012 ; 256 (3). 402-411
111. Herndon DN, Hart DW, Wolf SE, Chinkes DL, Wolfe RR. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med. 2001 ; 345 (17). 1223-1229
112. Aarsland A, Chinkes D, Wolfe RR, et al. Beta-blockade lowers peripheral lipolysis in burn patients receiving growth hormone: rate of hepatic very low density lipoprotein triglyceride secretion remains unchanged. Ann Surg. 1996 ; 223 (6). 777-789
113. Herndon DN, Barrow RE, Rutan TC, Minifee P, Jahoor F, Wolfe RR. Effect of propranolol administration on hemodynamic and metabolic responses of burned pediatric patients. Ann Surg. 1988 ; 208 (4). 484-492
114. Cree MG, Newcomer BR, Herndon DN, et al. PPAR-alpha agonism improves whole body and muscle mitochondrial fat oxidation, but does not alter intracellular fat concentrations in burn trauma children in a randomized controlled trial. Nutr Metab (Lond). 2007 ; 4: 9